Tumor and dendritic cell dual-targeting nanocarriers maximize the therapeutic potential of IDO1 inhibitor in vivo
Crossref DOI link: https://doi.org/10.1007/s12274-022-4597-7
Published Online: 2022-07-08
Published Print: 2022-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yu, Tong
Jin, Xiangyu
Yu, Fangying
Yang, Xiqin
Zeng, Yingping
Meng, Tingting
Yuan, Hong
Hu, Fuqiang
Text and Data Mining valid from 2022-07-08
Version of Record valid from 2022-07-08
Article History
Received: 26 April 2022
Revised: 24 May 2022
Accepted: 28 May 2022
First Online: 8 July 2022